España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Silence Therapeutics
SLN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$6.88
0.54
8.52%
At close: -
$6.54
-0.34
-4.94%
After Hours: 5:54 PM EDT
Get Report
Comment
Silence Therapeutics (SLN) Forecast
News
Earnings
Silence Therapeutics (SLN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Silence Therapeutics (NASDAQ:SLN) Stock
Silence Therapeutics Stock (NASDAQ: SLN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
Top 3 Health Care Stocks That May Explode In Q4
Avi Kapoor
Tuesday, December 10, 2024
The Analyst Landscape: 6 Takes On Silence Therapeutics
Benzinga Insights
Chardan Capital Maintains Buy on Silence Ther...
Benzinga Newsdesk
Wednesday, November 20, 2024
HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk
Tuesday, November 19, 2024
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
Vandana Singh
Top 3 Health Care Stocks You'll Regret Missing In Q4
Avi Kapoor
Monday, November 18, 2024
Silence Therapeutics Presents Late-Breaking P...
Benzinga Newsdesk
Friday, November 15, 2024
Analyst Scoreboard: 4 Ratings For Silence Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk
Thursday, November 14, 2024
Chardan Capital Maintains Buy on Silence Ther...
Benzinga Newsdesk
CORRECTION: Silence Therapeutics Q3 EPS $(0.7...
Benzinga Newsdesk
Tuesday, October 08, 2024
Morgan Stanley Reiterates Overweight on Silen...
Benzinga Newsdesk
Friday, August 30, 2024
HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk
Friday, August 16, 2024
Analyst Expectations For Silence Therapeutics's Future
Benzinga Insights
Chardan Capital Maintains Buy on Silence Ther...
Benzinga Newsdesk
Thursday, August 15, 2024
Silence Therapeutics Q2 EPS (11.10) Pence Dow...
Benzinga Newsdesk
Friday, June 28, 2024
Morgan Stanley Maintains Overweight on Silenc...
Benzinga Newsdesk
Chardan Capital Maintains Buy on Silence Ther...
Benzinga Newsdesk
Thursday, June 27, 2024
HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk
Silence Therapeutics Reports Results From Ong...
Benzinga Newsdesk
Monday, June 24, 2024
Silence Therapeutics To Receive $2M Research ...
Benzinga Newsdesk
Thursday, June 20, 2024
The Analyst Landscape: 6 Takes On Silence Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk
Silence Therapeutics Announces Topline 48-Wee...
Benzinga Newsdesk
Friday, May 31, 2024
HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk
Friday, May 24, 2024
HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk
Friday, May 17, 2024
HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk
What 7 Analyst Ratings Have To Say About Silence Therapeutics
Benzinga Insights
Chardan Capital Maintains Buy on Silence Ther...
Benzinga Newsdesk
Thursday, May 16, 2024
Silence Therapeutics Q1 Collaboration Revenue...
Benzinga Newsdesk
Monday, April 22, 2024
Beyond The Numbers: 7 Analysts Discuss Silence Therapeutics Stock
Benzinga Insights
Morgan Stanley Maintains Overweight on Silenc...
Benzinga Newsdesk
Monday, April 08, 2024
Silence Therapeutics Announces JAMA Publicati...
Benzinga Newsdesk
Friday, March 15, 2024
HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk
Thursday, March 14, 2024
These Analysts Boost Their Forecasts On Silence Therapeutics After Full Year 2023 Results
Avi Kapoor
Morgan Stanley Maintains Overweight on Silenc...
Benzinga Newsdesk
Chardan Capital Maintains Buy on Silence Ther...
Benzinga Newsdesk
Wednesday, March 13, 2024
What 4 Analyst Ratings Have To Say About Silence Therapeutics
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Silence ...
Benzinga Newsdesk
What's Going On With Silence Therapeutics Stock Today?
Nabaparna Bhattacharya
Silence Therapeutics Reported 2023 Revenue of...
Benzinga Newsdesk
Silence Therapeutics Announces Topline 36-Wee...
Benzinga Newsdesk
Earnings Scheduled For March 13, 2024
Benzinga Insights
Tuesday, March 12, 2024
Earnings Scheduled For March 12, 2024
Benzinga Insights
Friday, February 23, 2024
Silence Therapeutics Achieves $10M Milestone ...
Benzinga Newsdesk
Thursday, February 22, 2024
HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk
Monday, February 05, 2024
Silence Therapeutics Announces Oversubscribed...
Benzinga Newsdesk
Wednesday, January 31, 2024
Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Silence Therapeutics shares are trading highe...
Benzinga Newsdesk
BMO Capital Initiates Coverage On Silence The...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
